Clinical trials: Tic Disorders
Chronic Obstructive Pulmonary Disease
pCO2 Oscillations During Exercise: Relation to Cerebral Blood Flow and to Cognitive Dysfunction in COPD
Investigators wish to identify a relationship between substantial changes in carbon dioxide partial-pressure (pCO2), which frequently occur during the transitions from rest to exercise (ΔpCO2 >4 millimeters of mercury [mmHg] from…
- Trial name
- NCT02660437
- Testing
- Pulmonary Rehabilitation program
- Where
- Germany
- Volunteers
- 91 people
- Sponsor
- Schön Klinik Berchtesgadener Land
Tourette Syndrome
D-cycloserine Augmented Treatment for Youth With Tic Disorders
This pilot study aims evaluate the feasibility and initial efficacy of behavior therapy augmented by d-cycloserine (DCS) compared to behavior therapy augmented by placebo.
- Trial name
- NCT04357951
- Testing
- d-cycloserine, Behavior Therapy
- Where
- United States
- Sponsor
- Johns Hopkins University
Trigeminal Neuralgia
Research Study to Test Safety and Effectiveness of Investigational Drug in Patients With Trigeminal Neuralgia
This research study will look at the safety (e.g., the occurrence of side effects) and efficacy (how well the drug works in reducing trigeminal neuralgia attacks) of a drug called lamotrigine in adults with trigeminal neuralgia.
- Trial name
- NCT00203229
- Testing
- lamotrigine
- Where
- United States
- Volunteers
- 20 people
- Sponsor
- Thomas Jefferson University
Tourette's Syndrome
Study Evaluating The Safety And Efficacy Of PF-03654746 In Adult Subjects With Tourette's Syndrome
The purpose of this study is to evaluate the safety and efficacy of an investigational compound designated PF-03654746 compared to placebo in the treatment of adults with Tourette's Syndrome.
- Trial name
- NCT01475383
- Testing
- PF-03654746
- Where
- United States
- Sponsor
- Pfizer
Tics, Tourette Syndrome
Trial to Demonstrate the Efficacy and Safety of Internet-delivered Behavioral Treatment for Adults With Tic Disorders
Gilles da la Tourette syndrome (TS)* is a common chronic neuropsychiatric disorder characterized by motor and vocal tics. In most adult patients, quality of life is significantly impaired.
- Trial name
- ONLINE-TICS (NCT02605902)
- Testing
- (i)Comprehensive Behavioral Intervention for Tics, internet-delivered psychoeducation and relaxation training
- Where
- 5 sites in Germany
- Volunteers
- 161 people
- Sponsor
- Hannover Medical School
Tourette Syndrome
SCI-110 in the Treatment of Tourette Syndrome
To evaluate the efficacy, safety and tolerability of the cannabinoid-based medication SCI-110 compared to placebo in subjects with Tourette syndrome.
- Trial name
- NCT05126888
- Testing
- SCI-110
- Where
- 3 sites in United States, Germany and 1 more
- Volunteers
- 164 people
- Sponsor
- Neurothera Labs Inc.
Tourette Syndrome, Persistent Tic Disorder
Online Mindfulness-based Tic Reduction (Phase Two)
Tourette Syndrome (TS) and Persistent Tic Disorder (PTD) are chronic and potentially disabling neurobiological conditions. Although a range of pharmacological and psychosocial treatments exists, a significant number of…
- Trial name
- NCT03771235
- Testing
- Mindfulness-based Intervention for Tics, Tic Information and Coping Strategies
- Where
- 2 sites in United States
- Volunteers
- 37 people
- Sponsor
- Bowdoin College
Brain Injuries, Wounds and Injuries
Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children: A Pilot and Feasibility Study
Trauma is the leading cause of death and disability in children in the United States. The long-term goal of this project is to evaluate the benefits and harms of tranexamic acid (TXA; a drug that stops bleeding) in severely…
- Conditions
- Brain Injuries, Wounds and Injuries, Hemorrhage
- Trial name
- TIC-TOC (NCT02840097)
- Testing
- Tranexamic Acid
- Where
- 4 sites in United States
- Volunteers
- 31 people
- Sponsor
- Daniel Nishijima, MD, MAS